Literature DB >> 23020840

Aggressive continuous passive motion exercise does not improve knee range of motion after total knee arthroplasty.

Lan-Hui Chen1, Chung-Hwan Chen, Sung-Yen Lin, Song-Hsiung Chien, Jiing Yuan Su, Chao-Yung Huang, Hui-Yu Wang, Chih-Liang Chou, Tsung-Yu Tsai, Yuh-Min Cheng, Hsuan-Ti Huang.   

Abstract

AIMS AND
OBJECTIVES: The aim of this study was to evaluate the effects of continuous passive motion on the range of motion, postoperative pain and life quality of patients undergoing total knee arthroplasty within six months after the operation.
BACKGROUND: Total knee arthroplasty reduces pain and improves range of motion of the osteoarthritic knee joint. Continuous passive motion increases postoperative movement, but there is some controversy regarding whether aggressive continuous passive motion can improve range of motion or life quality, and whether it induces more pain.
DESIGN: A prospective controlled study was conducted in a medical centre in Taiwan from January to December 2006.
METHODS: One hundred and seven patients were recruited. The patients underwent the basic rehabilitation protocols (the control group) or the basic rehabilitation protocols and additional daily use of continuous passive motion for more than six hours per day (the experimental group). The range of motion, modified Short Form-36 (SF-36) and semi-quantitative visual analogue scale were recorded. Results.  Range of motion increased from 109° preoperatively to 125° at six months postoperatively in the treatment group and from 111° preoperatively to 125° at six months postoperatively in the control group. Visual analogue scale decreased from 7·78 preoperatively to 0·37 at six months postoperatively in the treatment group and from 7·92 preoperatively to 0·21 at six months postoperatively in the control group. The SF-36 improved from 3·76 preoperatively to 1·77 at six months postoperatively in the treatment group and from 3·68 preoperatively to 1·83 at six months postoperatively in the control group. There was no significant difference in range of motion, visual analogue scale and SF-36 between groups at each visit.
CONCLUSION: With the advances in total knee arthroplasty surgical technique, aggressive continuous passive motion does not provide obvious benefits. RELEVANCE TO CLINICAL PRACTICE: Total knee arthroplasty can alleviate pain and improve range of motion, but aggressive continuous passive motion does not provide additional benefits.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23020840     DOI: 10.1111/j.1365-2702.2012.04106.x

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  4 in total

1.  Use of continuous passive motion device after arthroscopic hip surgery decreases post-operative pain: A randomized controlled trial.

Authors:  Maria Munsch; Sravya P Vajapey; W Kelton Vasileff; Thomas Ellis; John DeWitt; John Ryan
Journal:  J Clin Orthop Trauma       Date:  2021-10-18

2.  Continuous passive motion and its effects on knee flexion after total knee arthroplasty in patients with knee osteoarthritis.

Authors:  Chun-De Liao; Yi-Ching Huang; Li-Fong Lin; Yen-Shuo Chiu; Jui-Chen Tsai; Chun-Lung Chen; Tsan-Hon Liou
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-19       Impact factor: 4.342

Review 3.  Drug-Free Interventions to Reduce Pain or Opioid Consumption After Total Knee Arthroplasty: A Systematic Review and Meta-analysis.

Authors:  Dario Tedesco; Davide Gori; Karishma R Desai; Steven Asch; Ian R Carroll; Catherine Curtin; Kathryn M McDonald; Maria P Fantini; Tina Hernandez-Boussard
Journal:  JAMA Surg       Date:  2017-10-18       Impact factor: 14.766

4.  Continuous passive motion not affect the knee motion and the surgical wound aspect after total knee arthroplasty.

Authors:  Sergi Gil-González; Ricardo Andrés Barja-Rodríguez; Antoni López-Pujol; Hussein Berjaoui; Jose Enrique Fernández-Bengoa; Juan Ignacio Erquicia; Joan Leal-Blanquet; Xavier Pelfort
Journal:  J Orthop Surg Res       Date:  2022-01-15       Impact factor: 2.359

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.